Urhy Asepsis Services And Consultants Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 25.00 K
as on 26-12-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue 16.82%
(FY 2020)
- Profit -17.29%
(FY 2020)
- Ebitda -144.06%
(FY 2020)
- Net Worth -0.92%
(FY 2020)
- Total Assets 70.22%
(FY 2020)
About Urhy Asepsis Services And Consultants
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 25.00 K , as per Ministry of Corporate Affairs (MCA) records.
Rekha and Yashuday Rawal serve as directors at the Company.
- CIN/LLPIN
U74999UP2017PTC096335
- Company No.
096335
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Urhy Asepsis Services And Consultants Private Limited offer?
Urhy Asepsis Services And Consultants Private Limited offers a wide range of products and services, including Machines & Equipments, Chain Link Machine, Wire Drawing & Cabling Machines, Electric Cable Making Machine, Bending & Metalwork Machines, Fastener Making Machine, Bar, Neodymium & Permanent Magnets, Magnetic Separators.
Who are the key members and board of directors at Urhy Asepsis Services And Consultants?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yashuday Rawal  | Director | 25-Aug-2017 | Current |
| Rekha | Director | 25-Aug-2017 | Current |
Financial Performance of Urhy Asepsis Services And Consultants.
Urhy Asepsis Services And Consultants Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 16.82% increase. The company also saw a substantial fall in profitability, with a 17.29% decrease in profit. The company's net worth dipped by a decrease of 0.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Urhy Asepsis Services And Consultants?
In 2019, Urhy Asepsis Services And Consultants had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Urhy Asepsis Services And Consultants?
Unlock and access historical data on people associated with Urhy Asepsis Services And Consultants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Urhy Asepsis Services And Consultants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urhy Asepsis Services And Consultants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
